This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

  Mobile version   RSS   Subscribe   Unsubscribe
Home   Join   Fellows' Corner Dec. 29, 2010
 
 
 
As 2010 comes to a close, ATAORG would like to wish its members, partners, and other industry professionals a safe and happy holiday season. As we reflect on the past year for the industry, we would like to provide the readers of the Thyroid Weekly, a look at the most accessed articles from the year. Our regular publication will resume next Wednesday, Jan. 5, 2011.


Thyroid cancer the fastest-growing cancer
The Daily Comet    Share    Share on FacebookTwitterShare on LinkedinE-mail article
June 24: Earlier this year, Laura Longueira locked herself in her bedroom for a week. No, it wasn't the stress of motherhood taking its toll - Longueira had just undergone radioactive iodine treatment for thyroid cancer, and posed a radiation risk to her family. She couldn't be around her husband or three kids; she couldn't help out around the house; she couldn't even share a bathroom. More

Can't lose weight? It may not be a lack of willpower
Aol Health    Share    Share on FacebookTwitterShare on LinkedinE-mail article
June 16:  The obesity problem in the United States has been blamed on poor food choices and "super-sized" portions, combined with a lack of exercise. Obese individuals are often looked upon as having a character defect, and the countless individuals having difficulty losing weight are usually told by their physicians that it is simply a matter of eating less and exercising more. This simplistic view taken by the overwhelming majority of physicians has resulted in the explosion of one fad diet after another - whether it be a low-fat, low-carbohydrate, low-glycemic, special food combination or a cave-man diet -  and some super new workout routines to "burn more fat in less time." The problem is that America is still getting fatter and fatter. More

Lymph node surgery for papillary thyroid cancer
Clinical Thyroidology for Patients    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Aug 18:  Papillary thyroid cancer is the most common form of thyroid cancer and, overall, has a good prognosis. However, up to seven percent of patients with Papillary thyroid cancer die from their cancer within 10 years of diagnosis. Local recurrences are found in five to 20 percent of patients with Papillary thyroid cancer and approximately 60 percent of these recurrences are localized to the lymph nodes of the neck. More

When a cancer therapy puts others at risk
The New York Times    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Oct. 27:  Doctors told Ann B. Maddox that she had thyroid cancer and that the cure was to swallow radioactive iodine, to kill the malignant cells. She traveled 500 miles from her home in Fayetteville, N.C., for treatment at Johns Hopkins Hospital in Baltimore. More

Rituximab and Graves Disease
Clinical Thyroidology    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Aug. 18:  The medical treatment of thyroid eye disease (TED) continues to be problematic. Glucocorticoid therapy provides acute control of periocular inflammation and long-term or high-dose glucocorticoid therapy is effective but associated with systemic side effects. More



Overview of the diseases which involve the thyroid hormone
Helium    Share    Share on FacebookTwitterShare on LinkedinE-mail article
July 1:  Thyroid hormone is a lipid soluble hormone which can penetrate the phospholipid bilayer of the cellular membrane. It exerts is effect by binding to nuclear receptors in the nucleus of the cell. Thus increasing the rate of protein synthesis in all the body tissues. Thyroid hormone is a derivative of the amino acid tyrosine. It requires iodide ion in order to function normally. More

In patients with thyroid cancer, total thyroidectomy and radioactive iodine improves the survival rate but not the cancer recurrence
Clinical Thyroidology for Patients    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Aug. 25:  In most patients with thyroid cancer, surgery is performed to remove the cancer and the entire thyroid gland. After surgery, many of these patients are treated with radioactive iodine to destroy all remaining cancerous or normal thyroid cells. In general, thyroid cancer is a low risk cancer since very few patients will die from their cancer. More

Lemon juice stimulation of salivary-gland flow increases the absorbed doses of 131I to the salivary glands after the administration of 131I
Clinical Thyroidology    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Sept. 22:  Radioiodine therapy with 131I is taken up by target tissues, including tumors and thyroid remnants, but is also taken up by the submandibular and parotid salivary glands. As a result, high levels of 131I therapy may be associated with salivary-gland damage, leading to long-term side effects, including sialadenitis, which occurs in about 30 percent of patients, and xerostomia, which has an incidence of about 10 to 20 percent. More

The rising incidence of thyroid cancer
The New York Times    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Oct. 27:  It's easy to crunch the numbers on thyroid cancer and assume it is a disease fast on the rise. Incidence has more than doubled since the early 1970s, and for women, it is the cancer with the fastest-growing number of new cases. But not every statistic tells the obvious tale. Despite the increase, thyroid cancer - a very treatable disease that develops in a butterfly-shaped gland in the neck - is still relatively uncommon. More

Thyroid surgery without the scar
News 8 Austin    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Nov. 3:  The thyroid gland, or simply the thyroid, is one of the largest endocrine glands in the body. The thyroid is found in the neck. It controls how quickly the body uses energy, makes proteins, and moderates how sensitive the body should be to other hormones that regulate the rate of metabolism and affect the growth and rate of function of many other systems in the body. More
 
 
ATA Thyroid Weekly News Briefs
ATA does not develop, exert any editorial or other control, or guarantee the accuracy, completeness, efficacy, or timeliness, of the materials, information, advertising or promotional activities ("Content") in this publication. Inclusion of Content in this publication does not constitute or imply endorsement, agreement, recommendation, or favoring by ATA of such information or the entities mentioned or promoted herein. Use of any Content appearing or referenced in this publication or obtained from advertisers is voluntary, and reliance on it should only be undertaken after an independent review by qualified experts. ATA is not responsible for, and expressly disclaims all liability for, damages of any kind arising out of use of, reference to, reliance on, or performance pursuant to such Content.

Colby Horton, Vice President of Publishing, 469.420.2601   Download media kit
Julie Bernhard, Content Editor, 469.420.2647   Contribute news
This edition of the ATA Weekly News Brief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
Recent issues
Dec. 15, 2010
Dec. 8, 2010
Dec. 1, 2010
Nov. 24, 2010



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063